Speaker Profile

Ph.D., Founder and CEO, Loop Genomics

Dr. Ben-Yehezkel founded Loop Genomics in 2016 as part of the Y-Combinator accelerator in order to disrupt the long-read sequencing space. Prior to Loop Genomics Dr. Ben-Yehezkel was the CEO and co-founder of Synvaccine, a viral synthetic genome engineering company and a Senior Scientist at the Weizmann Institute of Science, where he developed methods for engineering synthetic organisms. At Loop Genomics, he is directing the development and commercialization of the first hardware-free synthetic long read sequencing technology that can be used for any sequencing application. Loop’s technology transforms short-read sequencers into single-molecule long-read sequencers, offering the accuracy and resolution required for precision Microbiome, Transcriptome and DNA sequencing.

Clinical & Research Tools Showcase: Loop Genomics
Loop Genomics technology transforms short-read sequencers into long-read single-molecule machines for research and clinical applications.

Loop Genomics LoopSeqTM Single-Molecule Long-Read Sequencing
Loop Genomics has developed a sequencing technology that leverages existing Illumina short read sequencers coupled with barcoding technology to enable single-molecule, long-read sequencing on any Illumina infrastructure for Microbiome, Transcriptome, Targeted Amplicons and other applications.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.